{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:12:31Z","timestamp":1791177151212,"version":"4.1.0"},"reference-count":385,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,1]]},"DOI":"10.1210\/er.2007-0041","type":"journal-article","created":{"date-parts":[[2008,6,11]],"date-time":"2008-06-11T14:50:14Z","timestamp":1213195814000},"page":"465-493","source":"Crossref","is-referenced-by-count":247,"title":["Advances in Male Contraception"],"prefix":"10.1210","volume":"29","author":[{"given":"Stephanie T.","family":"Page","sequence":"first","affiliation":[{"name":"Center for Research in Reproduction and Contraception, Department of Medicine, University of Washington School of Medicine, Seattle, Washington 98195"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Amory","sequence":"additional","affiliation":[{"name":"Center for Research in Reproduction and Contraception, Department of Medicine, University of Washington School of Medicine, Seattle, Washington 98195"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Bremner","sequence":"additional","affiliation":[{"name":"Center for Research in Reproduction and Contraception, Department of Medicine, University of Washington School of Medicine, Seattle, Washington 98195"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2008,4,24]]},"reference":[{"key":"2019041121361769900_R1","author":"Population Division of the Department of Economic and Social Affairs of the United Nations","year":"2007"},{"key":"2019041121361769900_R2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2307\/2991522","article-title":"Unintended pregnancy in the United States.","volume":"30","author":"Henshaw","year":"1998","journal-title":"Fam Plann Perspect"},{"key":"2019041121361769900_R3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1363\/3500603","article-title":"Abortion incidence and services in the United States in 2000.","volume":"35","author":"Finer","year":"2003","journal-title":"Perspect Sex Reprod Health"},{"key":"2019041121361769900_R4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2307\/3097748","article-title":"Contraceptive use among U.S. women having abortions in 2000\u20132001.","volume":"34","author":"Jones","year":"2002","journal-title":"Perspect Sex Reprod Health"},{"key":"2019041121361769900_R5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/jurban\/jth122","article-title":"Unintended pregnancy among the urban poor.","volume":"81","author":"Besculides","year":"2004","journal-title":"J Urban Health"},{"key":"2019041121361769900_R6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0968-8080(06)27233-1","article-title":"Addressing Japan\u2019s fertility decline: influences of unintended pregnancy on child rearing.","volume":"14","author":"Goto","year":"2006","journal-title":"Reprod Health Matters"},{"key":"2019041121361769900_R7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1210\/er.2002-0002","article-title":"Male contraception.","volume":"23","author":"Anderson","year":"2002","journal-title":"Endocr Rev"},{"key":"2019041121361769900_R8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nm0496-398","article-title":"The myth of a male pill.","volume":"2","author":"Potts","year":"1996","journal-title":"Nat Med"},{"key":"2019041121361769900_R9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/j.1939-4640.2005.tb01077.x","article-title":"Expectations toward a novel male fertility control method and potential user types: results of a multinational survey.","volume":"26","author":"Heinemann","year":"2005","journal-title":"J Androl"},{"key":"2019041121361769900_R10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/humrep\/deh574","article-title":"Attitudes toward male fertility control: results of a multinational survey on four continents.","volume":"20","author":"Heinemann","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/humrep\/15.3.637","article-title":"Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations.","volume":"15","author":"Martin","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/humrep\/15.3.646","article-title":"Would women trust their partners to use a male pill?","volume":"15","author":"Glasier","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0010-7824(02)00360-8","article-title":"Migrant fathers and their attitudes to potential male hormonal contraceptives.","volume":"66","author":"Weston","year":"2002","journal-title":"Contraception"},{"key":"2019041121361769900_R14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5694\/j.1326-5377.2002.tb04374.x","article-title":"Will Australian men use male hormonal contraception? A survey of a postpartum population.","volume":"176","author":"Weston","year":"2002","journal-title":"Med J Aust"},{"key":"2019041121361769900_R15","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1093\/humrep\/del094","article-title":"Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men.","volume":"21","author":"Meriggiola","year":"2006","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.contraception.2005.10.012","article-title":"The acceptability of an injectable, once-a-month male contraceptive in China.","volume":"73","author":"Zhang","year":"2006","journal-title":"Contraception"},{"key":"2019041121361769900_R17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.contraception.2006.11.003","article-title":"Acceptability of a combination testosterone gel and depomedroxyprogesterone acetate male contraceptive regimen.","volume":"75","author":"Amory","year":"2007","journal-title":"Contraception"},{"key":"2019041121361769900_R18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)60313-4","article-title":"Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.","volume":"369","author":"Gray","year":"2007","journal-title":"Lancet"},{"key":"2019041121361769900_R19","first-page":"1","article-title":"Use of contraception and use of family planning services in the United States: 1982\u20132002.","volume":"350","author":"Mosher","year":"2004","journal-title":"Adv Data"},{"key":"2019041121361769900_R20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2307\/2991517","article-title":"Trends in contraceptive use in the United States: 1982\u20131995.","volume":"30","author":"Piccinino","year":"1998","journal-title":"Fam Plann Perspect"},{"key":"2019041121361769900_R21","author":"United Nations Department of Economic and Social","year":"2005"},{"key":"2019041121361769900_R22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2307\/2991640","article-title":"National Survey of Family Growth.","volume":"31","author":"Fu","year":"1999","journal-title":"Fam Plann Perspect"},{"key":"2019041121361769900_R23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.contraception.2004.03.009","article-title":"Contraceptive failure in the United States.","volume":"70","author":"Trussell","year":"2004","journal-title":"Contraception"},{"key":"2019041121361769900_R24","first-page":"1","article-title":"and 1990.","volume":"239","author":"Mosher","year":"1993","journal-title":"Adv Data"},{"key":"2019041121361769900_R25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2307\/2136208","article-title":"Condom characteristics: the perceptions and preferences of men in the United States.","volume":"25","author":"Grady","year":"1993","journal-title":"Fam Plann Perspect"},{"key":"2019041121361769900_R26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.contraception.2003.08.015","article-title":"Nonlatex vs. latex male condoms for contraception: a systematic review of randomized controlled trials.","volume":"68","author":"Gallo","year":"2003","journal-title":"Contraception"},{"key":"2019041121361769900_R27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00007435-199909000-00006","article-title":"Mechanical failure of the latex condom in a cohort of women at high STD risk.","volume":"26","author":"Macaluso","year":"1999","journal-title":"Sex Transm Dis"},{"key":"2019041121361769900_R28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0010-7824(03)00075-1","article-title":"Clinical breakage, slippage and acceptability of a new commercial polyurethane condom: a randomized, controlled study.","volume":"68","author":"Potter","year":"2003","journal-title":"Contraception"},{"key":"2019041121361769900_R29","first-page":"539","article-title":"Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial.","volume":"101","author":"Steiner","year":"2003","journal-title":"Obstet Gynecol"},{"key":"2019041121361769900_R30","first-page":"79","article-title":"Evaluation of the efficacy of a nonlatex condom: results from a randomized, controlled clinical trial.","volume":"35","author":"Walsh","year":"2003","journal-title":"Perspect Sex Reprod Health"},{"key":"2019041121361769900_R31","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1398-9995.1998.tb03827.x","article-title":"Allergy to latex condoms.","volume":"53","author":"Levy","year":"1998","journal-title":"Allergy"},{"key":"2019041121361769900_R32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/07853899409147905","article-title":"Allergy to natural rubber latex: a growing problem.","volume":"26","author":"Turjanmaa","year":"1994","journal-title":"Ann Med"},{"key":"2019041121361769900_R33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2307\/2991645","article-title":"Evaluation of the efficacy of a polyurethane condom: results from a randomized, controlled clinical trial.","volume":"31","author":"Frezieres","year":"1999","journal-title":"Fam Plann Perspect"},{"key":"2019041121361769900_R34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2105\/AJPH.89.1.92","article-title":"and 1995.","volume":"89","author":"Magnani","year":"1999","journal-title":"Am J Public Health"},{"key":"2019041121361769900_R35","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMcp044148","article-title":"Clinical practice. Long-acting methods of contraception.","volume":"353","author":"Peterson","year":"2005","journal-title":"N Engl J Med"},{"key":"2019041121361769900_R36","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/01.AOG.0000123246.11511.e4","article-title":"The risk of pregnancy after vasectomy.","volume":"103","author":"Jamieson","year":"2004","journal-title":"Obstet Gynecol"},{"key":"2019041121361769900_R37","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1464-410X.1984.tb06161.x","article-title":"Complications of vasectomy: review of 16,000 patients.","volume":"56","author":"Philp","year":"1984","journal-title":"Br J Urol"},{"key":"2019041121361769900_R38","first-page":"373","article-title":"cases.","volume":"76","author":"Schmidt","year":"1995","journal-title":"Br J Urol"},{"key":"2019041121361769900_R39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0022-5347(17)38334-9","article-title":"The no-scalpel vasectomy.","volume":"145","author":"Li","year":"1991","journal-title":"J Urol"},{"key":"2019041121361769900_R40","first-page":"2069","article-title":"Vasectomy: an update.","volume":"74","author":"Dassow","year":"2006","journal-title":"Am Fam Physician"},{"key":"2019041121361769900_R41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1464-410x.1999.00934.x","article-title":"An evaluation of the no-scalpel vasectomy technique.","volume":"83","author":"Kumar","year":"1999","journal-title":"BJU Int"},{"key":"2019041121361769900_R42","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/0140-6736(90)90487-P","article-title":"No-scalpel vasectomy at the King\u2019s birthday vasectomy festival.","volume":"335","author":"Nirapathpongporn","year":"1990","journal-title":"Lancet"},{"key":"2019041121361769900_R43","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1308\/003588405X71054","article-title":"Complications of vasectomy.","volume":"87","author":"Awsare","year":"2005","journal-title":"Ann R Coll Surg Engl"},{"key":"2019041121361769900_R44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1783\/147118902101196298","article-title":"A study to assess the prevalence of chronic testicular pain in post-vasectomy men compared to non-vasectomised men.","volume":"28","author":"Morris","year":"2002","journal-title":"J Fam Plann Reprod Health Care"},{"key":"2019041121361769900_R45","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0015-0282(00)00482-9","article-title":"Safety and effectiveness of vasectomy.","volume":"73","author":"Schwingl","year":"2000","journal-title":"Fertil Steril"},{"key":"2019041121361769900_R46","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0022-5347(01)65191-7","article-title":"Vasectomy reversal for treatment of the post-vasectomy pain syndrome.","volume":"157","author":"Myers","year":"1997","journal-title":"J Urol"},{"key":"2019041121361769900_R47","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/humrep\/13.7.1757","article-title":"Vasectomy related infertility: a major and costly medical problem.","volume":"13","author":"Jequier","year":"1998","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R48","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0022-5347(05)68819-2","article-title":"Patient characteristics associated with vasectomy reversal.","volume":"161","author":"Potts","year":"1999","journal-title":"J Urol"},{"key":"2019041121361769900_R49","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-5347(17)38381-7","article-title":"Results of 1,469 microsurgical vasectomy reversals by the Vasovasostomy Study Group.","volume":"145","author":"Belker","year":"1991","journal-title":"J Urol"},{"key":"2019041121361769900_R50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0897.1994.tb00849.x","article-title":"Risk factors for antisperm antibodies in infertile men.","volume":"31","author":"Heidenreich","year":"1994","journal-title":"Am J Reprod Immunol"},{"key":"2019041121361769900_R51","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1071\/RD9930135","article-title":"Anti-sperm antibodies and semen profiles in re-anastomosed men.","volume":"5","author":"Kay","year":"1993","journal-title":"Reprod Fertil Dev"},{"key":"2019041121361769900_R52","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0015-0282(16)53710-8","article-title":"Antisperm antibodies and fertility after vasovasostomy: a follow-up study of 216 men.","volume":"54","author":"Meinertz","year":"1990","journal-title":"Fertil Steril"},{"key":"2019041121361769900_R53","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJM199205213262104","article-title":"A long-term study of mortality in men who have undergone vasectomy.","volume":"326","author":"Giovannucci","year":"1992","journal-title":"N Engl J Med"},{"key":"2019041121361769900_R54","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/jama.1993.03500070053028","article-title":"A prospective cohort study of vasectomy and prostate cancer in US men.","volume":"269","author":"Giovannucci","year":"1993","journal-title":"JAMA"},{"key":"2019041121361769900_R55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0015-0282(98)00142-3","article-title":"The association between vasectomy and prostate cancer: a systematic review of the literature.","volume":"70","author":"Bernal-Delgado","year":"1998","journal-title":"Fertil Steril"},{"key":"2019041121361769900_R56","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1001\/jama.287.23.3110","article-title":"Vasectomy and risk of prostate cancer.","volume":"287","author":"Cox","year":"2002","journal-title":"JAMA"},{"key":"2019041121361769900_R57","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1210\/er.2002-0025","article-title":"The molecular action and regulation of the testis-determining factors, SRY (sex-determining region on the Y chromosome) and SOX9 [SRY-related high-mobility group (HMG) box 9].","volume":"24","author":"Harley","year":"2003","journal-title":"Endocr Rev"},{"key":"2019041121361769900_R58","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1126\/science.100883","article-title":"Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone.","volume":"202","author":"Belchetz","year":"1978","journal-title":"Science"},{"key":"2019041121361769900_R59","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1172\/JCI107454","article-title":"Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms.","volume":"52","author":"Santen","year":"1973","journal-title":"J Clin Invest"},{"key":"2019041121361769900_R60","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1210\/jcem-65-5-929","article-title":"Operating characteristics of the male hypothalamo-pituitary-gonadal axis: pulsatile release of testosterone and follicle-stimulating hormone and their temporal coupling with luteinizing hormone.","volume":"65","author":"Veldhuis","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R61","doi-asserted-by":"crossref","first-page":"10972","DOI":"10.1073\/pnas.1834399100","article-title":"Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54.","volume":"100","author":"Roux","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361769900_R62","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1056\/NEJMoa035322","article-title":"The GPR54 gene as a regulator of puberty.","volume":"349","author":"Seminara","year":"2003","journal-title":"N Engl J Med"},{"key":"2019041121361769900_R63","doi-asserted-by":"crossref","first-page":"34631","DOI":"10.1074\/jbc.M104847200","article-title":"The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54.","volume":"276","author":"Kotani","year":"2001","journal-title":"J Biol Chem"},{"key":"2019041121361769900_R64","doi-asserted-by":"crossref","first-page":"28969","DOI":"10.1074\/jbc.M102743200","article-title":"AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1.","volume":"276","author":"Muir","year":"2001","journal-title":"J Biol Chem"},{"key":"2019041121361769900_R65","first-page":"265","article-title":"Somatic alterations of the DPC4 and Madr2 genes in colorectal cancers and relationship to metastasis.","volume":"18","author":"Ohtaki","year":"2001","journal-title":"Int J Oncol"},{"key":"2019041121361769900_R66","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1210\/en.2005-1282","article-title":"Minireview: kisspeptin neurons as central processors in the regulation of gonadotropin-releasing hormone secretion.","volume":"147","author":"Dungan","year":"2006","journal-title":"Endocrinology"},{"key":"2019041121361769900_R67","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/en.2004-0413","article-title":"Developmental and hormonally regulated messenger ribonucleic acid expression of KiSS-1 and its putative receptor, GPR54, in rat hypothalamus and potent luteinizing hormone-releasing activity of KiSS-1 peptide.","volume":"145","author":"Navarro","year":"2004","journal-title":"Endocrinology"},{"key":"2019041121361769900_R68","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1210\/en.2005-0488","article-title":"Regulation of Kiss1 gene expression in the brain of the female mouse.","volume":"146","author":"Smith","year":"2005","journal-title":"Endocrinology"},{"key":"2019041121361769900_R69","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1210\/en.2005-1550","article-title":"Continuous human metastin 45\u201354 infusion desensitizes G protein-coupled receptor 54-induced gonadotropin-releasing hormone release monitored indirectly in the juvenile male Rhesus monkey (Macaca mulatta): a finding with therapeutic implications.","volume":"147","author":"Seminara","year":"2006","journal-title":"Endocrinology"},{"key":"2019041121361769900_R70","doi-asserted-by":"crossref","first-page":"E1074","DOI":"10.1152\/ajpendo.00040.2006","article-title":"Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats","volume":"291","author":"Thompson","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121361769900_R71","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1210\/jcem-58-4-609","article-title":"Modulation of pulsatile gonadotropin secretion by testosterone in man.","volume":"58","author":"Matsumoto","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R72","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1172\/JCI108237","article-title":"Is aromatization of testosterone to estradiol required for inhibition of luteinizing hormone secretion in men?","volume":"56","author":"Santen","year":"1975","journal-title":"J Clin Invest"},{"key":"2019041121361769900_R73","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1210\/jcem-67-6-1149","article-title":"Acute androgen receptor blockade increases luteinizing hormone secretory activity in men.","volume":"67","author":"Urban","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R74","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1210\/jcem-48-4-553","article-title":"Studies on the role of sex steroids in the feedback control of gonadotropin concentrations in men. III. Androgen resistance in primary gonadal failure.","volume":"48","author":"Winters","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R75","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1203\/00006450-199401000-00021","article-title":"Androgen-receptor blockade enhances pulsatile luteinizing hormone production in late pubertal males: evidence for a hypothalamic site of physiologic androgen feedback action.","volume":"35","author":"Kerrigan","year":"1994","journal-title":"Pediatr Res"},{"key":"2019041121361769900_R76","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1210\/jcem-59-5-963","article-title":"Effect of flutamide or cyproterone acetate on pituitary and testicular hormones in normal men.","volume":"59","author":"Knuth","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R77","first-page":"1227","article-title":"Evidence that androgen negative feedback regulates hypothalamic gonadotropin-releasing hormone impulse strength and the burst-like secretion of biologically active luteinizing hormone in men.","volume":"74","author":"Veldhuis","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R78","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0378-5122(85)90051-9","article-title":"Long-term transdermal dihydrotestosterone therapy: effects on pituitary gonadal axis and plasma lipoproteins.","volume":"7","author":"Vermeulen","year":"1985","journal-title":"Maturitas"},{"key":"2019041121361769900_R79","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/jcem-73-3-621","article-title":"Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and gonadotropin-releasing hormone-deficient men.","volume":"73","author":"Finkelstein","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R80","first-page":"3027","article-title":"Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback.","volume":"85","author":"Hayes","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R81","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1210\/jc.2006-0462","article-title":"In men, peripheral estradiol levels directly reflect the action of estrogens at the hypothalamo-pituitary level to inhibit gonadotropin secretion.","volume":"91","author":"Raven","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R82","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1530\/eje.1.02254","article-title":"Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback.","volume":"155","author":"Rochira","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2019041121361769900_R83","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/j.1939-4640.1994.tb01674.x","article-title":"The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol.","volume":"15","author":"Bagatell","year":"1994","journal-title":"J Androl"},{"key":"2019041121361769900_R84","first-page":"53","article-title":"Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion.","volume":"86","author":"Hayes","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R85","first-page":"2600","article-title":"Aromatization mediates testosterone\u2019s short-term feedback restraint of 24-hour endogenously driven and acute exogenous gonadotropin-releasing hormone-stimulated luteinizing hormone and follicle-stimulating hormone secretion in young men.","volume":"86","author":"Schnorr","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R86","first-page":"2749","article-title":"Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men\u2014a clinical research center study.","volume":"83","author":"Wang","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R87","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1210\/jc.2006-2203","article-title":"The effect of 5\u03b1-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men.","volume":"92","author":"Amory","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R88","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1210\/jcem.87.4.8138","article-title":"The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double-blind study.","volume":"87","author":"Kunelius","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R89","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1210\/jcem.86.9.7821","article-title":"A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency.","volume":"86","author":"Ly","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R90","first-page":"1086","article-title":"Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men.","volume":"79","author":"Belanger","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R91","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1677\/joe.1.06348","article-title":"Tissue expression of the nuclear progesterone receptor in male non-human primates and men.","volume":"189","author":"Luetjens","year":"2006","journal-title":"J Endocrinol"},{"key":"2019041121361769900_R92","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF02211799","article-title":"Estrogen and progesterone receptor mRNA are expressed in distinct pattern in male primate reproductive organs.","volume":"12","author":"Heikinheimo","year":"1995","journal-title":"J Assist Reprod Genet"},{"key":"2019041121361769900_R93","first-page":"895","article-title":"Immunocytochemical localization of progestin receptors in monkey hypothalamus: effect of estrogen and progestin.","volume":"130","author":"Bethea","year":"1992","journal-title":"Endocrinology"},{"key":"2019041121361769900_R94","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1210\/en.2005-0490","article-title":"Enhanced sexual behaviors and androgen receptor immunoreactivity in the male progesterone receptor knockout mouse.","volume":"146","author":"Schneider","year":"2005","journal-title":"Endocrinology"},{"key":"2019041121361769900_R95","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/j.1939-4640.2003.tb02695.x","article-title":"A review of androgen-progestin regimens for male contraception.","volume":"24","author":"Meriggiola","year":"2003","journal-title":"J Androl"},{"key":"2019041121361769900_R96","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1365-2265.2003.01751.x","article-title":"Demonstration of progesterone receptor-mediated gonadotrophin suppression in the human male.","volume":"58","author":"Brady","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121361769900_R97","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1210\/jc.2003-030616","article-title":"Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment.","volume":"89","author":"McLachlan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R98","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1210\/jc.2004-0793","article-title":"Coexistence of intracellular and membrane-bound progesterone receptors in human testis.","volume":"90","author":"Shah","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R99","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1210\/jc.2006-0222","article-title":"Direct effect of progestogen on gene expression in the testis during gonadotropin withdrawal and early suppression of spermatogenesis.","volume":"91","author":"Walton","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-2004-831893","article-title":"Inhibins in normal male physiology.","volume":"22","author":"O'Connor","year":"2004","journal-title":"Semin Reprod Med"},{"key":"2019041121361769900_R101","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/j.1939-4640.1999.tb02537.x","article-title":"Evidence that in a physiological setting Sertoli cell number is the major determinant of circulating concentrations of inhibin B in the adult male rhesus monkey (Macaca mulatta).","volume":"20","author":"Ramaswamy","year":"1999","journal-title":"J Androl"},{"key":"2019041121361769900_R102","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1210\/jc.2005-2564","article-title":"Activating mutations in the luteinizing hormone receptor gene: a human model of non-follicle-stimulating hormone-dependent inhibin production and germ cell maturation.","volume":"91","author":"Soriano-Guillen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R103","first-page":"3341","article-title":"Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction.","volume":"81","author":"Anawalt","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R104","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/humrep\/deg140","article-title":"Response of serum inhibin B and pro-\u03b1C levels to gonadotrophic stimulation in normal men before and after steroidal contraceptive treatment.","volume":"18","author":"Matthiesson","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R105","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199806113382404","article-title":"Male hypogonadism due to a mutation in the gene for the \u03b2-subunit of follicle-stimulating hormone.","volume":"338","author":"Phillip","year":"1998","journal-title":"N Engl J Med"},{"key":"2019041121361769900_R106","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ng0297-205","article-title":"Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility.","volume":"15","author":"Tapanainen","year":"1997","journal-title":"Nat Genet"},{"key":"2019041121361769900_R107","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0015-0282(02)03148-5","article-title":"Effects of follicle-stimulating hormone (FSH) and human chorionic gonadotropin in individuals with an inactivating mutation of the FSH receptor.","volume":"78","author":"Vaskivuo","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041121361769900_R108","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/humrep\/12.4.746","article-title":"Physiological relationships between inhibin B, follicle stimulating hormone secretion and spermatogenesis in normal men and response to gonadotrophin suppression by exogenous testosterone.","volume":"12","author":"Anderson","year":"1997","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R109","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1210\/jcem.86.11.8031","article-title":"Importance of inhibin B in the regulation of FSH secretion in the human male.","volume":"86","author":"Hayes","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R110","first-page":"1321","article-title":"Inhibin-B: a likely candidate for the physiologically important form of inhibin in men.","volume":"81","author":"Illingworth","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R111","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.fertnstert.2006.01.022","article-title":"Inhibin B is a better marker of spermatogenesis than other hormones in the evaluation of male factor infertility.","volume":"86","author":"Kumanov","year":"2006","journal-title":"Fertil Steril"},{"key":"2019041121361769900_R112","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1126\/science.76.1957.19","article-title":"Dual endocrine activity of the testes.","volume":"76","author":"McCullagh","year":"1932","journal-title":"Science"},{"key":"2019041121361769900_R113","doi-asserted-by":"crossref","first-page":"13692","DOI":"10.1073\/pnas.2232815100","article-title":"The low gonadotropin-independent constitutive production of testicular testosterone is sufficient to maintain spermatogenesis.","volume":"100","author":"Zhang","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361769900_R114","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1210\/en.2003-1049","article-title":"Molecular characterization of postnatal development of testicular steroidogenesis in luteinizing hormone receptor knockout mice.","volume":"145","author":"Zhang","year":"2004","journal-title":"Endocrinology"},{"key":"2019041121361769900_R115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/j.1939-4640.1985.tb03292.x","article-title":"Androgens in various fluid compartments of the rat testis and epididymis after hypophysectomy and gonadotropin supplementation.","volume":"6","author":"Turner","year":"1985","journal-title":"J Androl"},{"key":"2019041121361769900_R116","first-page":"E274","article-title":"Androgens in male rat reproductive tract fluids: hypophysectomy and steroid replacement","volume":"248","author":"Turner","year":"1985","journal-title":"Am J Physiol"},{"key":"2019041121361769900_R117","first-page":"902","article-title":"Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 \u03b1-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.","volume":"81","author":"Anderson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R118","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1439-0272.1978.tb03014.x","article-title":"Sex steroid production and secretion in the male.","volume":"10","author":"Horton","year":"1978","journal-title":"Andrologia"},{"key":"2019041121361769900_R119","first-page":"1492","article-title":"Determination of testosterone production rates in men and women using stable isotope\/dilution and mass spectrometry.","volume":"82","author":"Vierhapper","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0022-4731(74)90124-1","article-title":"Circadian variations of plasma testosterone and estrogens in normal men. A study by frequent sampling.","volume":"5","author":"Leymarie","year":"1974","journal-title":"J Steroid Biochem"},{"key":"2019041121361769900_R121","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0022-4731(73)90056-3","article-title":"Circadian rhythm of plasma testosterone, cortisol and gonadotropins in normal male subjects.","volume":"4","author":"Piro","year":"1973","journal-title":"J Steroid Biochem"},{"key":"2019041121361769900_R122","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1210\/jc.2003-031802","article-title":"Testosterone metabolic clearance and production rates determined by stable isotope dilution\/tandem mass spectrometry in normal men: influence of ethnicity and age.","volume":"89","author":"Wang","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R123","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1210\/jcem-56-6-1278","article-title":"Loss of circadian rhythmicity in blood testosterone levels with aging in normal men.","volume":"56","author":"Bremner","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R124","doi-asserted-by":"crossref","first-page":"R721","DOI":"10.1152\/ajpregu.00138.2005","article-title":"Age-specific changes in the regulation of LH-dependent testosterone secretion: assessing responsiveness to varying endogenous gonadotropin output in normal men","volume":"289","author":"Liu","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2019041121361769900_R125","doi-asserted-by":"crossref","first-page":"M163","DOI":"10.1093\/geronj\/43.6.M163","article-title":"Age-related alterations in the circadian rhythms of pulsatile luteinizing hormone and testosterone secretion in healthy men","volume":"43","author":"Tenover","year":"1988","journal-title":"J Gerontol"},{"key":"2019041121361769900_R126","doi-asserted-by":"crossref","first-page":"E775","DOI":"10.1152\/ajpendo.00410.2004","article-title":"Age diminishes the testicular steroidogenic response to repeated intravenous pulses of recombinant human LH during acute GnRH-receptor blockade in healthy men","volume":"288","author":"Veldhuis","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121361769900_R127","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199707103370204","article-title":"Effect of testosterone and estradiol in a man with aromatase deficiency.","volume":"337","author":"Carani","year":"1997","journal-title":"N Engl J Med"},{"key":"2019041121361769900_R128","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2003-030313","article-title":"Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment.","volume":"89","author":"Maffei","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R129","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1210\/jc.2005-0263","article-title":"The RsaI polymorphism in the estrogen receptor-\u03b2 gene is associated with male infertility.","volume":"90","author":"Aschim","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R130","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1056\/NEJM199410203311604","article-title":"Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.","volume":"331","author":"Smith","year":"1994","journal-title":"N Engl J Med"},{"key":"2019041121361769900_R131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jsbmb.2004.05.008","article-title":"Differential distribution of splice variants of estrogen receptor \u03b2 in human testicular cells suggests specific functions in spermatogenesis.","volume":"92","author":"Aschim","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121361769900_R132","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1677\/jme.0.0320279","article-title":"Human immature germ cells and ejaculated spermatozoa contain aromatase and oestrogen receptors.","volume":"32","author":"Lambard","year":"2004","journal-title":"J Mol Endocrinol"},{"key":"2019041121361769900_R133","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/01.ju.0000179540.28209.de","article-title":"Immunolocalization of androgen receptor and estrogen receptors \u03b1 and \u03b2 in human fetal testis and epididymis.","volume":"174","author":"Shapiro","year":"2005","journal-title":"J Urol"},{"key":"2019041121361769900_R134","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/j.1939-4640.2004.tb03164.x","article-title":"Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen.","volume":"25","author":"Coviello","year":"2004","journal-title":"J Androl"},{"key":"2019041121361769900_R135","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1210\/jc.2004-0802","article-title":"Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression.","volume":"90","author":"Coviello","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R136","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1210\/jcem-29-5-638","article-title":"Clomiphene citrate: a correlation of its effect on sperm concentration and morphology, total gonadotropins, ICSH, estrogen and testosterone excretion, and testicular cytology in normal men.","volume":"29","author":"Heller","year":"1969","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R137","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/j.1939-4640.1987.tb00975.x","article-title":"Pituitary-testicular function of prostatic cancer patients during treatment with a gonadotropin-releasing hormone agonist analog. I. Circulating hormone levels.","volume":"8","author":"Huhtaniemi","year":"1987","journal-title":"J Androl"},{"key":"2019041121361769900_R138","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1210\/jcem.87.2.8231","article-title":"Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men.","volume":"87","author":"McLachlan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R139","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1210\/jcem-37-6-882","article-title":"Testosterone concentrations in testes of normal men: effects of testosterone propionate administration.","volume":"37","author":"Morse","year":"1973","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R140","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1210\/jc.2005-0639","article-title":"Effects of testosterone and levonorgestrel combined with a 5\u03b1-reductase inhibitor or gonadotropin-releasing hormone antagonist on spermatogenesis and intratesticular steroid levels in normal men.","volume":"90","author":"Matthiesson","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R141"},{"key":"2019041121361769900_R142","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0015-0282(16)58221-1","article-title":"Contraceptive efficacy of testosterone-induced azoospermia and oligospermia in normal men.","volume":"65","year":"1996","journal-title":"Fertil Steril"},{"key":"2019041121361769900_R143","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/j.1939-4640.2002.tb02311.x","article-title":"Higher testosterone dose impairs sperm suppression induced by a combined androgen-progestin regimen.","volume":"23","author":"Meriggiola","year":"2002","journal-title":"J Androl"},{"key":"2019041121361769900_R144","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ncpendmet0069","article-title":"Recent advances in male hormonal contraception.","volume":"2","author":"Amory","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2019041121361769900_R145","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1196\/annals.1336.023","article-title":"The androgen microenvironment of the human testis and hormonal control of spermatogenesis.","volume":"1061","author":"Jarow","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"2019041121361769900_R146","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2164\/jandrol.107.002790","article-title":"Intratesticular androgens and spermatogenesis during severe gonadotropin suppression induced by male hormonal contraceptive treatment.","volume":"28","author":"Page","year":"2007","journal-title":"J Androl"},{"key":"2019041121361769900_R147","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1210\/endo-124-6-3043","article-title":"Maintenance of advanced spermatogenic cells in the adult rat testis: quantitative relationship to testosterone concentration within the testis.","volume":"124","author":"Zirkin","year":"1989","journal-title":"Endocrinology"},{"key":"2019041121361769900_R148","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/j.1939-4640.2001.tb02157.x","article-title":"Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride.","volume":"22","author":"Kinniburgh","year":"2001","journal-title":"J Androl"},{"key":"2019041121361769900_R149","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0010-7824(00)00139-6","article-title":"Efficacy and acceptability of testosterone implants, alone or in combination with a 5\u03b1-reductase inhibitor, for male hormonal contraception.","volume":"62","author":"McLachlan","year":"2000","journal-title":"Contraception"},{"key":"2019041121361769900_R150","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/er.2002-0032","article-title":"Androgen receptor in prostate cancer.","volume":"25","author":"Heinlein","year":"2004","journal-title":"Endocr Rev"},{"key":"2019041121361769900_R151","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000076816","article-title":"The androgen receptor in spermatogenesis.","volume":"103","author":"Collins","year":"2003","journal-title":"Cytogenet Genome Res"},{"key":"2019041121361769900_R152","doi-asserted-by":"crossref","first-page":"13498","DOI":"10.1073\/pnas.212474399","article-title":"Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues.","volume":"99","author":"Yeh","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361769900_R153","doi-asserted-by":"crossref","first-page":"18975","DOI":"10.1073\/pnas.0608565103","article-title":"Differential effects of spermatogenesis and fertility in mice lacking androgen receptor in individual testis cells.","volume":"103","author":"Tsai","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361769900_R154","doi-asserted-by":"crossref","first-page":"17718","DOI":"10.1073\/pnas.0608556103","article-title":"Oligozoospermia with normal fertility in male mice lacking the androgen receptor in testis peritubular myoid cells.","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361769900_R155","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1073\/pnas.0307306101","article-title":"Infertility with defective spermatogenesis and hypotestosteronemia in male mice lacking the androgen receptor in Sertoli cells.","volume":"101","author":"Chang","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361769900_R156","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1073\/pnas.0308114100","article-title":"A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis.","volume":"101","author":"De Gendt","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361769900_R157","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1242\/dev.00957","article-title":"Androgen receptor function is required in Sertoli cells for the terminal differentiation of haploid spermatids.","volume":"131","author":"Holdcraft","year":"2004","journal-title":"Development"},{"key":"2019041121361769900_R158","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1210\/me.2005-0113","article-title":"The effect of a Sertoli cell-selective knockout of the androgen receptor on testicular gene expression in prepubertal mice.","volume":"20","author":"Denolet","year":"2006","journal-title":"Mol Endocrinol"},{"key":"2019041121361769900_R159","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1210\/me.2006-0113","article-title":"Transcriptional profiling of androgen receptor (AR) mutants suggests instructive and permissive roles of AR signaling in germ cell development.","volume":"21","author":"Eacker","year":"2007","journal-title":"Mol Endocrinol"},{"key":"2019041121361769900_R160","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1210\/en.2006-0138","article-title":"Androgen receptor in Sertoli cell is essential for germ cell nursery and junctional complex formation in mouse testes.","volume":"147","author":"Wang","year":"2006","journal-title":"Endocrinology"},{"key":"2019041121361769900_R161","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/j.1939-4640.1999.tb02503.x","article-title":"Testosterone-dependent restoration of spermatogenesis in adult rats is impaired by a 5\u03b1-reductase inhibitor.","volume":"20","author":"O'Donnell","year":"1999","journal-title":"J Androl"},{"key":"2019041121361769900_R162","first-page":"719","article-title":"Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity.","volume":"104","author":"Kousteni","year":"2001","journal-title":"Cell"},{"key":"2019041121361769900_R163","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1074935","article-title":"Reversal of bone loss in mice by nongenotropic signaling of sex steroids.","volume":"298","author":"Kousteni","year":"2002","journal-title":"Science"},{"key":"2019041121361769900_R164","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI200317261","article-title":"Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids.","volume":"111","author":"Kousteni","year":"2003","journal-title":"J Clin Invest"},{"key":"2019041121361769900_R165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/bies.10249","article-title":"Sex steroids, ANGELS and osteoporosis.","volume":"25","author":"Moggs","year":"2003","journal-title":"Bioessays"},{"key":"2019041121361769900_R166","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1172\/JCI28809","article-title":"Bone protection by estrens occurs through non-tissue-selective activation of the androgen receptor.","volume":"116","author":"Windahl","year":"2006","journal-title":"J Clin Invest"},{"key":"2019041121361769900_R167","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1677\/jme.0.0210235","article-title":"Trinucleotide repeats in the human androgen receptor: a molecular basis for disease.","volume":"21","author":"Choong","year":"1998","journal-title":"J Mol Endocrinol"},{"key":"2019041121361769900_R168","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1093\/nar\/22.15.3181","article-title":"The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function.","volume":"22","author":"Chamberlain","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"2019041121361769900_R169","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.8303297","article-title":"Transcriptional activation modulated by homopolymeric glutamine and proline stretches.","volume":"263","author":"Gerber","year":"1994","journal-title":"Science"},{"key":"2019041121361769900_R170","first-page":"3893","article-title":"A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length.","volume":"87","author":"Dejager","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R171","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0090-4295(98)00468-3","article-title":"The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia.","volume":"53","author":"Giovannucci","year":"1999","journal-title":"Urology"},{"key":"2019041121361769900_R172","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1210\/jc.2004-1424","article-title":"X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients.","volume":"89","author":"Zitzmann","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R173","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0140-6736(98)08413-X","article-title":"Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene.","volume":"354","author":"Dowsing","year":"1999","journal-title":"Lancet"},{"key":"2019041121361769900_R174","first-page":"3777","article-title":"Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility.","volume":"82","author":"Tut","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R175","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1034\/j.1600-0412.2003.00068.x","article-title":"Long CAG repeats in the AR gene are not associated with infertility in Finnish males.","volume":"82","author":"Lund","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2019041121361769900_R176","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0022-5347(01)69098-0","article-title":"Is increased CAG repeat length in the androgen receptor gene a risk factor for male subfertility?","volume":"167","author":"Van Golde","year":"2002","journal-title":"J Urol"},{"key":"2019041121361769900_R177","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2164\/jandrol.106.000166","article-title":"No association of androgen receptor GGN repeat length polymorphism with infertility in Indian men.","volume":"27","author":"Rajender","year":"2006","journal-title":"J Androl"},{"key":"2019041121361769900_R178","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/molehr\/gah054","article-title":"Androgen receptor gene CAG and GGC repeat lengths in idiopathic male infertility.","volume":"10","author":"Ferlin","year":"2004","journal-title":"Mol Hum Reprod"},{"key":"2019041121361769900_R179","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/ncpuro0650","article-title":"Drug insight: testosterone preparations.","volume":"3","author":"Srinivas-Shankar","year":"2006","journal-title":"Nat Clin Pract Urol"},{"key":"2019041121361769900_R180","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/humupd\/dmh035","article-title":"Testosterone replacement therapy: current trends and future directions.","volume":"10","author":"Nieschlag","year":"2004","journal-title":"Hum Reprod Update"},{"key":"2019041121361769900_R181","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2164\/jandrol.106.000281","article-title":"Pharmacokinetics of testosterone undecanoate injected alone or in combination with norethisterone enanthate in healthy men.","volume":"27","author":"Qoubaitary","year":"2006","journal-title":"J Androl"},{"key":"2019041121361769900_R182","first-page":"1244","article-title":"Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception.","volume":"84","author":"Buchter","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R183","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1210\/jcem.87.8.8710","article-title":"Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.","volume":"87","author":"Gonzalo","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R184","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1210\/jcem.86.11.8028","article-title":"A novel male contraceptive pill-patch combination: oral desogestrel and transdermal testosterone in the suppression of spermatogenesis in normal men.","volume":"86","author":"Hair","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R185","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1210\/jc.2006-1411","article-title":"Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist.","volume":"91","author":"Page","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R186","doi-asserted-by":"crossref","first-page":"E1172","DOI":"10.1152\/ajpendo.2001.281.6.E1172","article-title":"Testosterone dose-response relationships in healthy young men","volume":"281","author":"Bhasin","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121361769900_R187","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/ijan.1995.18.5.237","article-title":"Testosterone enanthate at a dose of 200 mg\/week decreases HDL-cholesterol levels in healthy men.","volume":"18","author":"Meriggiola","year":"1995","journal-title":"Int J Androl"},{"key":"2019041121361769900_R188","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199607043350101","article-title":"The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.","volume":"335","author":"Bhasin","year":"1996","journal-title":"N Engl J Med"},{"key":"2019041121361769900_R189","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.1137741","article-title":"Male germline stem cells: from mice to men.","volume":"316","author":"Brinster","year":"2007","journal-title":"Science"},{"key":"2019041121361769900_R190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ncpendmet0098","article-title":"Technology insight: in vitro culture of spermatogonial stem cells and their potential therapeutic uses.","volume":"2","author":"Kubota","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2019041121361769900_R191","author":"de Kretser","year":"2002"},{"key":"2019041121361769900_R192","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1172\/JCI110327","article-title":"Follicle-stimulating hormone and human spermatogenesis.","volume":"68","author":"Bremner","year":"1981","journal-title":"J Clin Invest"},{"key":"2019041121361769900_R193","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/j.1939-4640.1985.tb00829.x","article-title":"Stimulation of sperm production by human chorionic gonadotropin after prolonged gonadotropin suppression in normal men.","volume":"6","author":"Matsumoto","year":"1985","journal-title":"J Androl"},{"key":"2019041121361769900_R194","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1210\/jcem-62-6-1184","article-title":"Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man.","volume":"62","author":"Matsumoto","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R195","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1172\/JCI111024","article-title":"Reinitiation of sperm production in gonadotropin-suppressed normal men by administration of follicle-stimulating hormone.","volume":"72","author":"Matsumoto","year":"1983","journal-title":"J Clin Invest"},{"key":"2019041121361769900_R196","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1210\/jc.2006-1145","article-title":"The relative roles of follicle-stimulating hormone and luteinizing hormone in maintaining spermatogonial maturation and spermiation in normal men.","volume":"91","author":"Matthiesson","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R197","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1210\/rp.57.1.149","article-title":"Identification of specific sites of hormonal regulation in spermatogenesis in rats, monkeys, and man.","volume":"57","author":"McLachlan","year":"2002","journal-title":"Recent Prog Horm Res"},{"key":"2019041121361769900_R198","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/j.1939-4640.1999.tb03382.x","article-title":"FSH immunoneutralization acutely impairs spermatogonial development in normal adult rats.","volume":"20","author":"Meachem","year":"1999","journal-title":"J Androl"},{"key":"2019041121361769900_R199","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1210\/endo.138.7.5381","article-title":"Immunization of male bonnet monkeys (M. radiata) with a recombinant FSH receptor preparation affects testicular function and fertility.","volume":"138","author":"Moudgal","year":"1997","journal-title":"Endocrinology"},{"key":"2019041121361769900_R200","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1210\/endo.137.5.8612566","article-title":"Specific immunoneutralization of FSH leads to apoptotic cell death of the pachytene spermatocytes and spermatogonial cells in the rat.","volume":"137","author":"Shetty","year":"1996","journal-title":"Endocrinology"},{"key":"2019041121361769900_R201","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1210\/endo.141.8.7628","article-title":"Spermiation failure is a major contributor to early spermatogenic suppression caused by hormone withdrawal in adult rats.","volume":"141","author":"Saito","year":"2000","journal-title":"Endocrinology"},{"key":"2019041121361769900_R202","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/j.1939-4640.2001.tb03444.x","article-title":"Structure and control of a cell-cell adhesion complex associated with spermiation in rat seminiferous epithelium.","volume":"22","author":"Chapin","year":"2001","journal-title":"J Androl"},{"key":"2019041121361769900_R203","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0070-2153(07)80002-0","article-title":"Junction restructuring and spermatogenesis: the biology, regulation, and implication in male contraceptive development.","volume":"80","author":"Yan","year":"2007","journal-title":"Curr Top Dev Biol"},{"key":"2019041121361769900_R204","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1745-7262.2007.00285.x","article-title":"Sperm maturation in the epididymis: a new look at an old problem.","volume":"9","author":"Cooper","year":"2007","journal-title":"Asian J Androl"},{"key":"2019041121361769900_R205","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1095\/biolreprod.103.026302","article-title":"Androgen-regulated genes in the murine epididymis.","volume":"71","author":"Chauvin","year":"2004","journal-title":"Biol Reprod"},{"key":"2019041121361769900_R206","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1095\/biolreprod.106.057323","article-title":"The rat epididymal transcriptome: comparison of segmental gene expression in the rat and mouse epididymides.","volume":"76","author":"Jelinsky","year":"2007","journal-title":"Biol Reprod"},{"key":"2019041121361769900_R207","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1745-7262.2007.00317.x","article-title":"Identification of epididymis-specific transcripts in the mouse and rat by transcriptional profiling.","volume":"9","author":"Johnston","year":"2007","journal-title":"Asian J Androl"},{"key":"2019041121361769900_R208","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1021\/pr050324s","article-title":"Proteomic profiling of regionalized proteins in rat epididymis indicates consistency between specialized distribution and protein functions.","volume":"5","author":"Yuan","year":"2006","journal-title":"J Proteome Res"},{"key":"2019041121361769900_R209","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.mce.2005.12.043","article-title":"Epididymis-specific promoter-driven gene targeting: a transcription factor which regulates epididymis-specific gene expression.","volume":"250","author":"Suzuki","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121361769900_R210","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1093\/humrep\/deh466","article-title":"Volume regulation of mature and immature spermatozoa in a primate model, and possible ion channels involved.","volume":"19","author":"Yeung","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R211","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.mce.2005.12.030","article-title":"Physiological volume regulation by spermatozoa.","volume":"250","author":"Yeung","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121361769900_R212","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3181\/00379727-40-10527P","article-title":"Production of oligospermia in a man by the use of testosterone propionate.","volume":"40","author":"Heckel","year":"1939","journal-title":"Proc Soc Exp Biol Med"},{"key":"2019041121361769900_R213","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1210\/jc.2002-021997","article-title":"Editorial: hormonal male contraception\u2013lessons from the East when the Western market fails.","volume":"88","author":"Handelsman","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R214","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0015-0282(16)57307-5","article-title":"Factors in nonuniform induction of azoospermia by testosterone enanthate in normal men. World Health Organization Task Force on Methods for the Regulation of Male Fertility.","volume":"63","author":"Handelsman","year":"1995","journal-title":"Fertil Steril"},{"key":"2019041121361769900_R215","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2164\/jandrol.107.002683","article-title":"7\u03b1-Methyl-19-nortestosterone (MENT) vs testosterone in combination with etonogestrel implants for spermatogenic suppression in healthy men.","volume":"28","author":"Walton","year":"2007","journal-title":"J Androl"},{"key":"2019041121361769900_R216","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1210\/jc.2005-1743","article-title":"Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese men.","volume":"91","author":"Wang","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R217","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1210\/jc.2002-020447","article-title":"A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men.","volume":"88","author":"Gu","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R218","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1210\/jc.2003-030107","article-title":"Contraceptive efficacy of a depot progestin and androgen combination in men.","volume":"88","author":"Turner","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R219","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2164\/jandrol.106.002311","article-title":"10th Summit meeting consensus: recommendations for regulatory approval for hormonal male contraception.","volume":"28","author":"Aaltonen","year":"2007","journal-title":"J Androl"},{"key":"2019041121361769900_R220","first-page":"561","article-title":"Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men.","volume":"79","author":"Bagatell","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R221","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/j.1939-4640.2002.tb02272.x","article-title":"Contraceptive steroids influence the hemostatic activation state in healthy men.","volume":"23","author":"Zitzmann","year":"2002","journal-title":"J Androl"},{"key":"2019041121361769900_R222","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.1210\/jc.2005-0847","article-title":"Endogenous progesterone and the exogenous progestin norethisterone enanthate are associated with a proinflammatory profile in healthy men.","volume":"90","author":"Zitzmann","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R223","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0010-7824(01)00223-2","article-title":"Testosterone for male contraception during one year: attitudes, well-being and quality of sex life.","volume":"64","author":"Sjogren","year":"2001","journal-title":"Contraception"},{"key":"2019041121361769900_R224","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2307\/2136111","article-title":"Evidence for the acceptability of an injectable hormonal method for men.","volume":"27","author":"Ringheim","year":"1995","journal-title":"Fam Plann Perspect"},{"key":"2019041121361769900_R225","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1530\/acta.0.0790366","article-title":"Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate.","volume":"79","author":"Nieschlag","year":"1975","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2019041121361769900_R226","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/j.1939-4640.1998.tb02086.x","article-title":"A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.","volume":"19","author":"Zhang","year":"1998","journal-title":"J Androl"},{"key":"2019041121361769900_R227","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1530\/eje.0.1400414","article-title":"Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies.","volume":"140","author":"Behre","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"2019041121361769900_R228","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0015-0282(97)00363-4","article-title":"An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in men.","volume":"68","author":"Meriggiola","year":"1997","journal-title":"Fertil Steril"},{"key":"2019041121361769900_R229","first-page":"3642","article-title":"A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men.","volume":"84","author":"Zhang","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1365-2265.2000.01024.x","article-title":"Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception.","volume":"53","author":"Kamischke","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121361769900_R231","first-page":"303","article-title":"Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception.","volume":"86","author":"Kamischke","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R232","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1210\/jcem-66-3-546","article-title":"Transdermal testosterone therapy in the treatment of male hypogonadism.","volume":"66","author":"Ahmed","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R233","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1210\/jc.2002-021058","article-title":"AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function.","volume":"88","author":"Steidle","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R234","first-page":"964","article-title":"Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study.","volume":"85","author":"Wang","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R235","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1530\/eje.1.01878","article-title":"Norethisterone enanthate has neither a direct effect on the testis nor on the epididymis: a study in adult male cynomolgus monkeys (Macaca fascicularis).","volume":"152","author":"Junaidi","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2019041121361769900_R236","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2307\/1965869","article-title":"Current efforts to develop male hormonal contraception.","volume":"9","author":"Schearer","year":"1978","journal-title":"Stud Fam Plann"},{"key":"2019041121361769900_R237","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0010-7824(79)90084-2","article-title":"Pregnancies associated with sperm concentrations below 10 million\/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters.","volume":"20","author":"Barfield","year":"1979","journal-title":"Contraception"},{"key":"2019041121361769900_R238","first-page":"757","article-title":"Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.","volume":"81","author":"Bebb","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R239","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2164\/jandrol.04135","article-title":"Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.","volume":"26","author":"Anawalt","year":"2005","journal-title":"J Androl"},{"key":"2019041121361769900_R240","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/j.1939-4640.1999.tb02535.x","article-title":"A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations.","volume":"20","author":"Anawalt","year":"1999","journal-title":"J Androl"},{"key":"2019041121361769900_R241","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/j.1939-4640.2004.tb02846.x","article-title":"Male hormonal contraception: suppression of spermatogenesis by injectable testosterone undecanoate alone or with levonorgestrel implants in Chinese men.","volume":"25","author":"Gui","year":"2004","journal-title":"J Androl"},{"key":"2019041121361769900_R242","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0015-0282(00)01490-4","article-title":"Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression.","volume":"74","author":"Anawalt","year":"2000","journal-title":"Fertil Steril"},{"key":"2019041121361769900_R243","first-page":"112","article-title":"Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism.","volume":"84","author":"Wu","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R244","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1093\/humrep\/17.11.2869","article-title":"Investigation of hormonal male contraception in African men: suppression of spermatogenesis by oral desogestrel with depot testosterone.","volume":"17","author":"Anderson","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R245","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/17.6.1490","article-title":"Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men.","volume":"17","author":"Kinniburgh","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R246","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1210\/jc.2004-0895","article-title":"A multicenter phase IIb study of a novel combination of intramuscular androgen (testosterone decanoate) and oral progestogen (etonogestrel) for male hormonal contraception.","volume":"90","author":"Hay","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R247","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1210\/jcem.87.8.8773","article-title":"Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception.","volume":"87","author":"Anderson","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R248","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/humrep\/dei300","article-title":"A multicentre study investigating subcutaneous etonogestrel implants with injectable testosterone decanoate as a potential long-acting male contraceptive.","volume":"21","author":"Brady","year":"2006","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R249","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/0022-4731(86)90320-1","article-title":"Pharmacology of antiandrogens.","volume":"25","author":"Neumann","year":"1986","journal-title":"J Steroid Biochem"},{"key":"2019041121361769900_R250","first-page":"3018","article-title":"A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.","volume":"81","author":"Meriggiola","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R251","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/humrep\/13.5.1225","article-title":"Low dose of cyproterone acetate and testosterone enanthate for contraception in men.","volume":"13","author":"Meriggiola","year":"1998","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R252","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1210\/jcem.87.5.8514","article-title":"Twenty-one day administration of dienogest reversibly suppresses gonadotropins and testosterone in normal men.","volume":"87","author":"Meriggiola","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R253","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2265.2000.01097.x","article-title":"Potential of norethisterone enanthate for male contraception: pharmacokinetics and suppression of pituitary and gonadal function.","volume":"53","author":"Kamischke","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121361769900_R254","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1210\/jc.2004-1852","article-title":"Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate.","volume":"90","author":"Meriggiola","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R255","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1210\/jcem.87.2.8218","article-title":"An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations.","volume":"87","author":"Kamischke","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R256","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1210\/jc.2003-031307","article-title":"Male hormonal contraception: effects of injections of testosterone undecanoate and depot medroxyprogesterone acetate at eight-week intervals in Chinese men.","volume":"89","author":"Gu","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R257","first-page":"84","article-title":"Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.","volume":"74","author":"Behre","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R258","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jcem-73-6-1360","article-title":"Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.","volume":"73","author":"Pavlou","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R259","first-page":"476","article-title":"Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.","volume":"75","author":"Tom","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R260","first-page":"427","article-title":"Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.","volume":"77","author":"Bagatell","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R261","first-page":"3527","article-title":"Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone.","volume":"83","author":"Swerdloff","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R262","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1093\/humrep\/16.12.2570","article-title":"Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone.","volume":"16","author":"Behre","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R263","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0022-5347(05)66353-7","article-title":"The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancer.","volume":"165","author":"Tomera","year":"2001","journal-title":"J Urol"},{"key":"2019041121361769900_R264","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1210\/jc.2003-032123","article-title":"A single dose of the potent gonadotropin-releasing hormone antagonist acyline suppresses gonadotropins and testosterone for 2 weeks in healthy young men.","volume":"89","author":"Herbst","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R265","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1200\/JCO.2005.05.1458","article-title":"Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosis.","volume":"24","author":"Lin","year":"2006","journal-title":"J Clin Oncol"},{"key":"2019041121361769900_R266","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1210\/jc.2006-1110","article-title":"Suppression of serum luteinizing hormone in postmenopausal women by an orally administered nonpeptide antagonist of the gonadotropin-releasing hormone receptor (NBI-42902).","volume":"91","author":"Struthers","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R267","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0022-5347(05)00649-X","article-title":"Efficacy and safety of histrelin subdermal implant in patients with advanced prostate cancer.","volume":"175","author":"Schlegel","year":"2006","journal-title":"J Urol"},{"key":"2019041121361769900_R268","first-page":"262","article-title":"Liver damage from long-term methyltestosterone.","volume":"2","author":"Westaby","year":"1977","journal-title":"Lancet"},{"key":"2019041121361769900_R269","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1592\/phco.23.3.319.32104","article-title":"Important effect of food on the bioavailability of oral testosterone undecanoate.","volume":"23","author":"Bagchus","year":"2003","journal-title":"Pharmacotherapy"},{"key":"2019041121361769900_R270","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000178904","article-title":"Oral testosterone, a reappraisal.","volume":"9","author":"Daggett","year":"1978","journal-title":"Horm Res"},{"key":"2019041121361769900_R271","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0140-6736(00)74069-4","article-title":"Clinical administration of androgens.","volume":"1","author":"Foss","year":"1939","journal-title":"Lancet"},{"key":"2019041121361769900_R272","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0140-6736(74)90216-5","article-title":"Therapeutic effectiveness of oral testosterone.","volume":"2","author":"Johnsen","year":"1974","journal-title":"Lancet"},{"key":"2019041121361769900_R273","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1210\/jc.2004-1221","article-title":"Oral testosterone in oil plus dutasteride in men: a pharmacokinetic study.","volume":"90","author":"Amory","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R274","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2164\/jandrol.05058","article-title":"Oral testosterone in oil: pharmacokinetic effects of 5\u03b1 reduction by finasteride or dutasteride and food intake in men.","volume":"27","author":"Amory","year":"2006","journal-title":"J Androl"},{"key":"2019041121361769900_R275","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1210\/en.2005-1524","article-title":"Dimethandrolone undecanoate: a new potent orally active androgen with progestational activity.","volume":"147","author":"Attardi","year":"2006","journal-title":"Endocrinology"},{"key":"2019041121361769900_R276","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s11095-006-9024-3","article-title":"Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands.","volume":"23","author":"Gao","year":"2006","journal-title":"Pharm Res"},{"key":"2019041121361769900_R277","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(06)68614-5","article-title":"Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis.","volume":"367","author":"Liu","year":"2006","journal-title":"Lancet"},{"key":"2019041121361769900_R278","year":"1999","edition":"4"},{"key":"2019041121361769900_R279","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ajog.2004.01.061","article-title":"Safety concerns and health benefits associated with oral contraception","volume":"190","author":"Burkman","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121361769900_R280","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1677\/joe.0.1700027","article-title":"Proof of the effect of testosterone on skeletal muscle.","volume":"170","author":"Bhasin","year":"2001","journal-title":"J Endocrinol"},{"key":"2019041121361769900_R281","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1210\/jcem.82.8.4163","article-title":"Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.","volume":"82","author":"Behre","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R282","first-page":"2670","article-title":"Effects of testosterone replacement in hypogonadal men.","volume":"85","author":"Snyder","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R283","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1210\/jc.2002-020918","article-title":"The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone.","volume":"88","author":"Herbst","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R284","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsbmb.2005.02.014","article-title":"Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.","volume":"96","author":"Campagnoli","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121361769900_R285","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/humrep\/dei300","article-title":"A multicentre study investigating subcutaneous etonogestrel implants with injectable testosterone decanoate as a potential long-acting male contraceptive.","volume":"21","author":"Brady","year":"2006","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R286","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1158\/1055-9965.EPI-04-0715","article-title":"Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy.","volume":"14","author":"Parsons","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019041121361769900_R287","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/j.1939-4640.2003.tb02676.x","article-title":"Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan.","volume":"24","author":"Bhasin","year":"2003","journal-title":"J Androl"},{"key":"2019041121361769900_R288","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1001\/jama.1996.03540230054035","article-title":"Occult prostate cancer in men with low serum testosterone levels.","volume":"276","author":"Morgentaler","year":"1996","journal-title":"JAMA"},{"key":"2019041121361769900_R289","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/pros.1046","article-title":"High-grade prostate cancer is associated with low serum testosterone levels.","volume":"47","author":"Schatzl","year":"2001","journal-title":"Prostate"},{"key":"2019041121361769900_R290","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0022-5347(01)65871-3","article-title":"The effect of exogenous testosterone on total and free prostate specific antigen levels in healthy young men.","volume":"156","author":"Cooper","year":"1996","journal-title":"J Urol"},{"key":"2019041121361769900_R291","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1210\/jc.2003-031110","article-title":"Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone.","volume":"89","author":"Amory","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R292","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/jc.2004-1933","article-title":"Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.","volume":"90","author":"Page","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R293","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer.","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"},{"key":"2019041121361769900_R294","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2605.2000.00004.x","article-title":"7\u03b1-Methyl-19-nortestosterone (MENT): the optimal androgen for male contraception and replacement therapy.","volume":"23(Suppl 2)","author":"Sundaram","year":"2000","journal-title":"Int J Androl"},{"key":"2019041121361769900_R295","first-page":"4212","article-title":"Prostate-sparing effects in primates of the potent androgen 7\u03b1-methyl-19-nortestosterone: a potential alternative to testosterone for androgen replacement and male contraception.","volume":"83","author":"Cummings","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R296","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/humrep\/12.5.967","article-title":"Pharmacokinetics and pharmacodynamics of 7\u03b1-methyl-19-nortestosterone after intramuscular administration in healthy men.","volume":"12","author":"Suvisaari","year":"1997","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R297","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/humrep\/14.9.2200","article-title":"Gonadotrophin and testosterone suppression by 7\u03b1-methyl-19-nortestosterone acetate administered by subdermal implant to healthy men.","volume":"14","author":"Noe","year":"1999","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R298","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1210\/jc.2002-022043","article-title":"A clinical trial of 7 \u03b1-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men.","volume":"88","author":"Eckardstein","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R299","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2164\/jandrol.107.002683","article-title":"7\u03b1-Methyl-19-nortestosterone (MENT) vs. testosterone in combination with etonogestrel implants for spermatogenic suppression in normal men.","volume":"28","author":"Walton","year":"2007","journal-title":"J Androl"},{"key":"2019041121361769900_R300","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.toxlet.2006.12.004","article-title":"Characterisation of the pharmacological profile of desoxymethyltestosterone (Madol), a steroid misused for doping.","volume":"169","author":"Diel","year":"2007","journal-title":"Toxicol Lett"},{"key":"2019041121361769900_R301","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1677\/joe.1.05997","article-title":"Tetrahydrogestrinone induces a genomic signature typical of a potent anabolic steroid.","volume":"184","author":"Labrie","year":"2005","journal-title":"J Endocrinol"},{"key":"2019041121361769900_R302","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1210\/jc.2004-0033","article-title":"Tetrahydrogestrinone is a potent androgen and progestin.","volume":"89","author":"Death","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R303","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/en.2006-0843","article-title":"Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats.","volume":"148","author":"Ostrowski","year":"2007","journal-title":"Endocrinology"},{"key":"2019041121361769900_R304","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/en.2006-0793","article-title":"An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate.","volume":"148","author":"Miner","year":"2007","journal-title":"Endocrinology"},{"key":"2019041121361769900_R305","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1021\/jm061329j","article-title":"Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones.","volume":"50","author":"Higuchi","year":"2007","journal-title":"J Med Chem"},{"key":"2019041121361769900_R306","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1124\/jpet.104.075424","article-title":"A selective androgen receptor modulator for hormonal male contraception.","volume":"312","author":"Chen","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"2019041121361769900_R307","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1210\/en.2005-0572","article-title":"Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats.","volume":"146","author":"Gao","year":"2005","journal-title":"Endocrinology"},{"key":"2019041121361769900_R308","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/j.1939-4640.2001.tb03445.x","article-title":"Daily testosterone and gonadotropin levels are similar in azoospermic and nonazoospermic normal men administered weekly testosterone: implications for male contraceptive development.","volume":"22","author":"Amory","year":"2001","journal-title":"J Androl"},{"key":"2019041121361769900_R309","first-page":"290","article-title":"Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.","volume":"77","author":"Wallace","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R310","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1210\/en.2004-0913","article-title":"Testosterone replacement therapy induces spermatogenesis and partially restores fertility in luteinizing hormone receptor knockout mice.","volume":"146","author":"Pakarainen","year":"2005","journal-title":"Endocrinology"},{"key":"2019041121361769900_R311","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1210\/jc.2004-0575","article-title":"A novel circulating hormone of testis origin in humans.","volume":"89","author":"Foresta","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R312","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1210\/jc.2005-1865","article-title":"The effects of gonadotropin suppression and selective replacement on insulin-like factor 3 secretion in normal adult men.","volume":"91","author":"Bay","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R313","doi-asserted-by":"crossref","first-page":"7323","DOI":"10.1073\/pnas.0307061101","article-title":"Paracrine regulation of mammalian oocyte maturation and male germ cell survival.","volume":"101","author":"Kawamura","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361769900_R314","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2164\/jandrol.106.002345","article-title":"Elevated end-of-treatment serum INSL3 is associated with failure to completely suppress spermatogenesis in men receiving male hormonal contraception.","volume":"28","author":"Amory","year":"2007","journal-title":"J Androl"},{"key":"2019041121361769900_R315","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1365-2265.2002.01652.x","article-title":"CAG repeat length in the androgen receptor gene and gonadotrophin suppression influence the effectiveness of hormonal male contraception.","volume":"57","author":"Eckardstein","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121361769900_R316","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1210\/jcem.86.9.7793","article-title":"Pharmacogenetic polymorphisms of the AR and metabolism and susceptibility to hormone-induced azoospermia.","volume":"86","author":"Yu","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R317","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0015-0282(16)59419-9","article-title":"Clinical trial of gossypol as a male contraceptive drug. Part II. Hypokalemia study.","volume":"48","author":"Liu","year":"1987","journal-title":"Fertil Steril"},{"key":"2019041121361769900_R318","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0015-0282(16)59418-7","article-title":"Clinical trial of gossypol as a male contraceptive drug. Part I. Efficacy study.","volume":"48","author":"Liu","year":"1987","journal-title":"Fertil Steril"},{"key":"2019041121361769900_R319","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2605.1988.tb01211.x","article-title":"Recovery of sperm production following the cessation of gossypol treatment: a two-centre study in China.","volume":"11","author":"Meng","year":"1988","journal-title":"Int J Androl"},{"key":"2019041121361769900_R320","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1365-2605.1998.00092.x","article-title":"Gossypol: reasons for its failure to be accepted as a safe, reversible male antifertility drug.","volume":"21","author":"Waites","year":"1998","journal-title":"Int J Androl"},{"key":"2019041121361769900_R321","first-page":"283","article-title":"Low dose gossypol for male contraception.","volume":"2","author":"Gu","year":"2000","journal-title":"Asian J Androl"},{"key":"2019041121361769900_R322","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0010-7824(87)90104-1","article-title":"Tripterygium wilfordii, a Chinese herb effective in male fertility regulation.","volume":"36","author":"Qian","year":"1987","journal-title":"Contraception"},{"key":"2019041121361769900_R323","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0010-7824(93)90036-7","article-title":"Male antifertility compounds from Tripterygium wilfordii Hook f.","volume":"47","author":"Matlin","year":"1993","journal-title":"Contraception"},{"key":"2019041121361769900_R324","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/j.1939-4640.2000.tb02137.x","article-title":"Long-term effects of triptolide on spermatogenesis, epididymal sperm function, and fertility in male rats.","volume":"21","author":"Huynh","year":"2000","journal-title":"J Androl"},{"key":"2019041121361769900_R325","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/j.1939-4640.1998.tb02042.x","article-title":"Triptolide: a potential male contraceptive.","volume":"19","author":"Lue","year":"1998","journal-title":"J Androl"},{"key":"2019041121361769900_R326","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1210\/jc.2005-1808","article-title":"Transient testicular warming enhances the suppressive effect of testosterone on spermatogenesis in adult cynomolgus monkeys (Macaca fascicularis).","volume":"91","author":"Lue","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R327","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/j.1939-4640.2002.tb02336.x","article-title":"Mild testicular hyperthermia induces profound transitional spermatogenic suppression through increased germ cell apoptosis in adult cynomolgus monkeys (Macaca fascicularis).","volume":"23","author":"Lue","year":"2002","journal-title":"J Androl"},{"key":"2019041121361769900_R328","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(16)59640-X","article-title":"Role of temperature in regulation of spermatogenesis and the use of heating as a method for contraception.","volume":"49","author":"Kandeel","year":"1988","journal-title":"Fertil Steril"},{"key":"2019041121361769900_R329","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1210\/endo.140.4.6629","article-title":"Single exposure to heat induces stage-specific germ cell apoptosis in rats: role of intratesticular testosterone on stage specificity.","volume":"140","author":"Lue","year":"1999","journal-title":"Endocrinology"},{"key":"2019041121361769900_R330","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0015-0282(97)81525-7","article-title":"Effect of increased scrotal temperature on sperm production in normal men.","volume":"68","author":"Wang","year":"1997","journal-title":"Fertil Steril"},{"key":"2019041121361769900_R331","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1210\/jc.2007-0367","article-title":"Transient scrotal hyperthermia and levonorgestrel enhance testosterone induced spermatogenesis suppression in men through increased germ cell apoptosis.","volume":"92","author":"Wang","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R332","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1210\/en.2006-1487","article-title":"Development of l-CDB-4022 as a nonsteroidal male oral contraceptive: induction and recovery from severe oligospermia in the adult male cynomolgus monkey (Macaca fascicularis).","volume":"148","author":"Hild","year":"2007","journal-title":"Endocrinology"},{"key":"2019041121361769900_R333","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2164\/jandrol.106.002295","article-title":"Acute adverse effects of the indenopyridine CDB-4022 on the ultrastructure of Sertoli cells, spermatocytes, and spermatids in rat testes: comparison to the known Sertoli cell toxicant di-n-pentylphthalate (DPP).","volume":"28","author":"Hild","year":"2007","journal-title":"J Androl"},{"key":"2019041121361769900_R334","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1095\/biolreprod65.6.1771","article-title":"Disruption of spermatogenesis and Sertoli cell structure and function by the indenopyridine CDB-4022 in rats.","volume":"65","author":"Hild","year":"2001","journal-title":"Biol Reprod"},{"key":"2019041121361769900_R335","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1095\/biolreprod.103.026989","article-title":"The ability of a gonadotropin-releasing hormone antagonist, acyline, to prevent irreversible infertility induced by the indenopyridine, CDB-4022, in adult male rats: the role of testosterone.","volume":"71","author":"Hild","year":"2004","journal-title":"Biol Reprod"},{"key":"2019041121361769900_R336","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1095\/biolreprod64.5.1500","article-title":"Reversible inhibition of spermatogenesis in rats using a new male contraceptive, 1-(2,4-dichlorobenzyl)-indazole-3-carbohydrazide.","volume":"64","author":"Grima","year":"2001","journal-title":"Biol Reprod"},{"key":"2019041121361769900_R337","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1095\/biolreprod.102.011379","article-title":"Sertoli-germ cell adherens junction dynamics in the testis are regulated by RhoB GTPase via the ROCK\/LIMK signaling pathway.","volume":"68","author":"Lui","year":"2003","journal-title":"Biol Reprod"},{"key":"2019041121361769900_R338","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1210\/en.2002-221035","article-title":"Adhering junction dynamics in the testis are regulated by an interplay of \u03b21-integrin and focal adhesion complex-associated proteins.","volume":"144","author":"Siu","year":"2003","journal-title":"Endocrinology"},{"key":"2019041121361769900_R339","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm1420","article-title":"A male contraceptive targeting germ cell adhesion.","volume":"12","author":"Mruk","year":"2006","journal-title":"Nat Med"},{"key":"2019041121361769900_R340","doi-asserted-by":"crossref","first-page":"8642","DOI":"10.1128\/MCB.24.19.8642-8648.2004","article-title":"Targeted deletion of the epididymal receptor HE6 results in fluid dysregulation and male infertility.","volume":"24","author":"Davies","year":"2004","journal-title":"Mol Cell Biol"},{"key":"2019041121361769900_R341","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mce.2005.12.024","article-title":"New approaches for male fertility control: HE6 as an example of a putative target.","volume":"250","author":"Gottwald","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121361769900_R342","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.mce.2005.12.034","article-title":"Epididymal secreted protein Crisp-1 and sperm function.","volume":"250","author":"Roberts","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121361769900_R343","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1745-7262.2007.00318.x","article-title":"Structure and function of epididymal protein cysteine-rich secretory protein-1.","volume":"9","author":"Roberts","year":"2007","journal-title":"Asian J Androl"},{"key":"2019041121361769900_R344","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1071\/RD05120","article-title":"Moving to the beat: a review of mammalian sperm motility regulation.","volume":"18","author":"Turner","year":"2006","journal-title":"Reprod Fertil Dev"},{"key":"2019041121361769900_R345","doi-asserted-by":"crossref","first-page":"22623","DOI":"10.1074\/jbc.C000200200","article-title":"Requirement of seminolipid in spermatogenesis revealed by UDP-galactose: ceramide galactosyltransferase-deficient mice.","volume":"275","author":"Fujimoto","year":"2000","journal-title":"J Biol Chem"},{"key":"2019041121361769900_R346","doi-asserted-by":"crossref","first-page":"12147","DOI":"10.1073\/pnas.95.21.12147","article-title":"Complex gangliosides are essential in spermatogenesis of mice: possible roles in the transport of testosterone.","volume":"95","author":"Takamiya","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361769900_R347","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1172\/JCI29224","article-title":"Mutation of \u03b2-glucosidase 2 causes glycolipid storage disease and impaired male fertility.","volume":"116","author":"Yildiz","year":"2006","journal-title":"J Clin Invest"},{"key":"2019041121361769900_R348","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1025902113005","article-title":"The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement.","volume":"26","author":"Cox","year":"2003","journal-title":"J Inherit Metab Dis"},{"key":"2019041121361769900_R349","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/B:BOLI.0000045756.54006.17","article-title":"Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease.","volume":"27","author":"Elstein","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"2019041121361769900_R350","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.clinthera.2005.08.004","article-title":"An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment.","volume":"27","author":"Pastores","year":"2005","journal-title":"Clin Ther"},{"key":"2019041121361769900_R351","doi-asserted-by":"crossref","first-page":"17173","DOI":"10.1073\/pnas.262586099","article-title":"Reversible infertility in male mice after oral administration of alkylated imino sugars: a nonhormonal approach to male contraception.","volume":"99","author":"Spoel","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361769900_R352","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/humrep\/del414","article-title":"Miglustat has no apparent effect on spermatogenesis in normal men.","volume":"22","author":"Amory","year":"2007","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R353","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7827-5-1","article-title":"The sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study.","volume":"5","author":"Bone","year":"2007","journal-title":"Reprod Biol Endocrinol"},{"key":"2019041121361769900_R354","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35098027","article-title":"A sperm ion channel required for sperm motility and male fertility.","volume":"413","author":"Ren","year":"2001","journal-title":"Nature"},{"key":"2019041121361769900_R355","doi-asserted-by":"crossref","first-page":"18945","DOI":"10.1074\/jbc.M701083200","article-title":"CatSperbeta, a novel transmembrane protein in the CatSper channel complex.","volume":"282","author":"Liu","year":"2007","journal-title":"J Biol Chem"},{"key":"2019041121361769900_R356","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1073\/pnas.0610286104","article-title":"All four CatSper ion channel proteins are required for male fertility and sperm cell hyperactivated motility.","volume":"104","author":"Qi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361769900_R357","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1095\/biolreprod.106.054064","article-title":"The role of potassium chloride cotransporters in murine and human sperm volume regulation.","volume":"75","author":"Klein","year":"2006","journal-title":"Biol Reprod"},{"key":"2019041121361769900_R358","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/molehr\/7.9.819","article-title":"Effects of the ion-channel blocker quinine on human sperm volume, kinematics and mucus penetration, and the involvement of potassium channels.","volume":"7","author":"Yeung","year":"2001","journal-title":"Mol Hum Reprod"},{"key":"2019041121361769900_R359","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ydbio.2006.10.004","article-title":"Compartmentalization of a unique ADP\/ATP carrier protein SFEC (sperm flagellar energy carrier, AAC4) with glycolytic enzymes in the fibrous sheath of the human sperm flagellar principal piece.","volume":"302","author":"Kim","year":"2007","journal-title":"Dev Biol"},{"key":"2019041121361769900_R360","doi-asserted-by":"crossref","first-page":"16501","DOI":"10.1073\/pnas.0407708101","article-title":"Glyceraldehyde 3-phosphate dehydrogenase-S, a sperm-specific glycolytic enzyme, is required for sperm motility and male fertility.","volume":"101","author":"Miki","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361769900_R361","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/j.1939-4640.2000.tb02111.x","article-title":"Human glyceraldehyde 3-phosphate dehydrogenase-2 gene is expressed specifically in spermatogenic cells.","volume":"21","author":"Welch","year":"2000","journal-title":"J Androl"},{"key":"2019041121361769900_R362","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1126\/science.289.5479.625","article-title":"Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor.","volume":"289","author":"Chen","year":"2000","journal-title":"Science"},{"key":"2019041121361769900_R363","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1073\/pnas.0400050101","article-title":"Mice deficient for soluble adenylyl cyclase are infertile because of a severe sperm-motility defect.","volume":"101","author":"Esposito","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361769900_R364","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ydbio.2006.05.038","article-title":"Soluble adenylyl cyclase (sAC) is indispensable for sperm function and fertilization.","volume":"296","author":"Xie","year":"2006","journal-title":"Dev Biol"},{"key":"2019041121361769900_R365","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.devcel.2005.06.007","article-title":"The \u201csoluble\u201d adenylyl cyclase in sperm mediates multiple signaling events required for fertilization.","volume":"9","author":"Hess","year":"2005","journal-title":"Dev Cell"},{"key":"2019041121361769900_R366","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/ncb1072","article-title":"A new sperm-specific Na+\/H+ exchanger required for sperm motility and fertility.","volume":"5","author":"Wang","year":"2003","journal-title":"Nat Cell Biol"},{"key":"2019041121361769900_R367","doi-asserted-by":"crossref","first-page":"9325","DOI":"10.1073\/pnas.0611296104","article-title":"A sperm-specific Na+\/H+ exchanger (sNHE) is critical for expression and in vivo bicarbonate regulation of the soluble adenylyl cyclase (sAC).","volume":"104","author":"Wang","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121361769900_R368","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nature03362","article-title":"The immunoglobulin superfamily protein Izumo is required for sperm to fuse with eggs.","volume":"434","author":"Inoue","year":"2005","journal-title":"Nature"},{"key":"2019041121361769900_R369","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0010-7824(93)90082-I","article-title":"Phase I clinical trial of an injectable contraceptive for the male.","volume":"48","author":"Guha","year":"1993","journal-title":"Contraception"},{"key":"2019041121361769900_R370","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0010-7824(97)00142-X","article-title":"Phase II clinical trial of a vas deferens injectable contraceptive for the male.","volume":"56","author":"Guha","year":"1997","journal-title":"Contraception"},{"key":"2019041121361769900_R371","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/humrep\/deh332","article-title":"Studies on the membrane integrity of human sperm treated with a new injectable male contraceptive.","volume":"19","author":"Chaudhury","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R372","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1745-7262.2007.00244.x","article-title":"Biophysical mechanism-mediated time-dependent effect on sperm of human and monkey vas implanted polyelectrolyte contraceptive.","volume":"9","author":"Guha","year":"2007","journal-title":"Asian J Androl"},{"key":"2019041121361769900_R373","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2818.2007.01795.x","article-title":"Quantitative analysis of surface micro-roughness alterations in human spermatozoa using atomic force microscopy.","volume":"227","author":"Kumar","year":"2007","journal-title":"J Microsc"},{"key":"2019041121361769900_R374","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2164\/jandrol.05192","article-title":"Antisperm immunity for contraception.","volume":"27","author":"Naz","year":"2006","journal-title":"J Androl"},{"key":"2019041121361769900_R375","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1126\/science.1099743","article-title":"Reversible immunocontraception in male monkeys immunized with eppin.","volume":"306","author":"O'Rand","year":"2004","journal-title":"Science"},{"key":"2019041121361769900_R376","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.mce.2005.12.039","article-title":"Eppin: an effective target for male contraception.","volume":"250","author":"O'Rand","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121361769900_R377","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1093\/humrep\/dei256","article-title":"Recent advances in contraceptive vaccine development: a mini-review.","volume":"20","author":"Naz","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041121361769900_R378","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/S0140-6736(05)60336-4","article-title":"Research into anti-fertility vaccine continues despite protests.","volume":"352","author":"Kumar","year":"1998","journal-title":"Lancet"},{"key":"2019041121361769900_R379","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/humupd\/3.4.335","article-title":"Development of male contraceptive vaccine\u2014a perspective.","volume":"3","author":"Moudgal","year":"1997","journal-title":"Hum Reprod Update"},{"key":"2019041121361769900_R380","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1016\/j.vaccine.2007.01.089","article-title":"Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes suppresses fertility in vivo.","volume":"25","author":"Khan","year":"2007","journal-title":"Vaccine"},{"key":"2019041121361769900_R381","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2605.1988.tb00994.x","article-title":"Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.","volume":"11","author":"Guerin","year":"1988","journal-title":"Int J Androl"},{"key":"2019041121361769900_R382","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0006-3223(01)01148-9","article-title":"Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men.","volume":"50","author":"Seidman","year":"2001","journal-title":"Biol Psychiatry"},{"key":"2019041121361769900_R383","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1365-2605.2001.00319.x","article-title":"Combination of subcutaneous levonorgestrel implants and transdermal dihydrotestosterone gel for male hormonal contraception.","volume":"24","author":"Pollanen","year":"2001","journal-title":"Int J Androl"},{"key":"2019041121361769900_R384","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1210\/jc.2003-030574","article-title":"Testosterone undecanoate maintains spermatogenic suppression induced by cyproterone acetate plus testosterone undecanoate in normal men.","volume":"88","author":"Meriggiola","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121361769900_R385","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1093\/humrep\/deh491","article-title":"Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception.","volume":"19","author":"Brady","year":"2004","journal-title":"Hum Reprod"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/29\/4\/465\/8863169\/edrv0465.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T03:12:35Z","timestamp":1709003555000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/29\/4\/465\/2355036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,24]]},"references-count":385,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2008,4,24]]},"published-print":{"date-parts":[[2008,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2007-0041","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,24]]}}}